These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22693246)

  • 1. IFN-γ-independent intraocular tumor rejection is mediated by a macrophage-dependent process that leaves the eye intact.
    Coursey TG; Chen PW; Niederkorn JY
    J Leukoc Biol; 2012 Nov; 92(5):939-50. PubMed ID: 22693246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ T-cell-dependent tumour rejection in an immune-privileged environment requires macrophages.
    Dace DS; Chen PW; Niederkorn JY
    Immunology; 2008 Mar; 123(3):367-77. PubMed ID: 17944931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-{gamma}-dependent manner.
    Dace DS; Chen PW; Alizadeh H; Niederkorn JY
    J Leukoc Biol; 2007 Feb; 81(2):421-9. PubMed ID: 17077163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors.
    Coursey TG; Chen PW; Niederkorn JY
    Cancer Res; 2011 Apr; 71(7):2445-54. PubMed ID: 21307132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye.
    Coursey TG; Chen PW; Niederkorn JY
    J Immunol; 2011 Oct; 187(8):4219-28. PubMed ID: 21918192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T cells circumvent immune privilege in the eye and mediate intraocular tumor rejection by a TNF-alpha-dependent mechanism.
    Dace DS; Chen PW; Niederkorn JY
    J Immunol; 2007 May; 178(10):6115-22. PubMed ID: 17475837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye.
    Wang S; Boonman ZF; Li HC; He Y; Jager MJ; Toes RE; Niederkorn JY
    J Immunol; 2003 Sep; 171(6):2789-96. PubMed ID: 12960299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interferon-γ and cytotoxic T lymphocytes in intraocular tumor rejection.
    Ligocki AJ; Brown JR; Niederkorn JY
    J Leukoc Biol; 2016 May; 99(5):735-47. PubMed ID: 26578649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenectomy promotes indirect elimination of intraocular tumors by CD8+ T cells that is associated with IFNγ- and Fas/FasL-dependent activation of intratumoral macrophages.
    Miller MR; Mandell JB; Beatty KM; Harvey SA; Rizzo MJ; Previte DM; Thorne SH; McKenna KC
    Cancer Immunol Res; 2014 Dec; 2(12):1175-85. PubMed ID: 25248763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
    Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
    J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Killer T Cells Contribute to Neutrophil Recruitment and Ocular Tissue Damage in a Model of Intraocular Tumor Rejection.
    Ligocki AJ; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):813-23. PubMed ID: 26934137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection of intraocular tumors by CD4(+) T cells without induction of phthisis.
    Schurmans LR; Diehl L; den Boer AT; Sutmuller RP; Boonman ZF; Medema JP; van der Voort EI; Laman J; Melief CJ; Jager MJ; Toes RE
    J Immunol; 2001 Nov; 167(10):5832-7. PubMed ID: 11698457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages are vital in spontaneous intraocular tumor eradication.
    Boonman ZF; Schurmans LR; van Rooijen N; Melief CJ; Toes RE; Jager MJ
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2959-65. PubMed ID: 16799039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic evaluation of spontaneous regression of an intraocular murine melanoma.
    Knisely TL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):247-57. PubMed ID: 2154414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An M2 Rather than a T
    Lee DH; Ghiasi H
    J Virol; 2018 May; 92(10):. PubMed ID: 29491152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of CD80+ costimulation for rejection of ocular tumors and termination of immune privilege.
    Chen PW; Uno T; Ksander BR
    Exp Eye Res; 2006 Sep; 83(3):574-83. PubMed ID: 16643898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic analysis of intraocular allogeneic tumors in mice.
    Luckenbach MW; Streilein JW; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1985 Oct; 26(10):1368-76. PubMed ID: 3930419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful immunotherapy of an intraocular tumor in mice.
    Schurmans LR; den Boer AT; Diehl L; van der Voort EI; Kast WM; Melief CJ; Toes RE; Jager MJ
    Cancer Res; 1999 Oct; 59(20):5250-4. PubMed ID: 10537305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate IFN-γ promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages.
    Dungan LS; McGuinness NC; Boon L; Lynch MA; Mills KH
    Eur J Immunol; 2014 Oct; 44(10):2903-17. PubMed ID: 25056715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous immune rejection of intraocular tumors in mice.
    Niederkorn JY; Meunier PC
    Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):877-84. PubMed ID: 3924853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.